![]() |
Prostate Cancer |
Free Subscription
1 Acta Radiol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
The diagnostic performance and reader agreement of the Prostate Imaging for
Recurrence Reporting system in the evaluation of local recurrence in patients
with biochemically recurrent prostate cancer.
Acta Radiol. 2025 Apr 23:2841851251334364. doi: 10.1177/02841851251334364.
PubMed
Abstract available
Perioperative complications of focal therapy for prostate cancer: results from
the GeRmAn Nationwide inpatient Data (GRAND) study.
BJU Int. 2025 Apr 19. doi: 10.1111/bju.16746.
PubMed
Abstract available
Percentage of free to total PSA as a biomarker of survival in metastatic
castration-resistant prostate cancer.
BJU Int. 2025 Apr 25. doi: 10.1111/bju.16751.
PubMed
Abstract available
NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic
prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label,
randomised controlled trial.
BMC Cancer. 2025;25:768.
PubMed
Abstract available
MBs(NRP2)-based ultrasound molecular imaging for early diagnosis of
castration-resistant prostate cancer.
BMC Cancer. 2025;25:769.
PubMed
Abstract available
Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant
prostate cancer.
Br J Cancer. 2025 Apr 19. doi: 10.1038/s41416-025-02993.
PubMed
Abstract available
Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and
concordance with MpMRI.
Cancer Imaging. 2025;25:55.
PubMed
Abstract available
PSMA-based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and
the Future.
Curr Treat Options Oncol. 2025 Apr 23. doi: 10.1007/s11864-025-01317.
PubMed
Abstract available
Re: Darolutamide in Combination with Androgen-deprivation Therapy in Patients
with Metastatic Hormone-sensitive Prostate Cancer from the Phase III ARANOTE
Trial.
Eur Urol. 2025 Apr 23:S0302-2838(25)00208-8. doi: 10.1016/j.eururo.2025.
PubMed
Re: [(177)Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic
Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre,
Randomised, Phase 2 Trial.
Eur Urol. 2025 Apr 22:S0302-2838(25)00207-6. doi: 10.1016/j.eururo.2025.
PubMed
Impact of the COVID-19 Pandemic on Prostate Cancer: Perturbations in Screening
and Diagnostic Patterns.
Int J Urol. 2025 Apr 24. doi: 10.1111/iju.70085.
PubMed
Abstract available
Complementing Anticancer Therapy: Antibody-Drug Conjugates Targeting CD46 as
Prostate Cancer Treatment.
J Clin Oncol. 2025 Apr 22:JCO2500457. doi: 10.1200/JCO-25-00457.
PubMed
Editorial for "Prostate Cancer Risk Stratification and Scan Tailoring Using Deep
Learning With Abbreviated Prostate MRI".
J Magn Reson Imaging. 2025 Apr 23. doi: 10.1002/jmri.29806.
PubMed
Prostate Cancer Risk Stratification and Scan Tailoring Using Deep Learning on
Abbreviated Prostate MRI.
J Magn Reson Imaging. 2025 Apr 22. doi: 10.1002/jmri.29798.
PubMed
Abstract available
Evidence-Based Clinical Protocols to Monitor Efficacy of [(177)Lu]Lu-PSMA
Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer
Using Real-World Data.
J Nucl Med. 2025 Apr 24:jnumed.124.269431. doi: 10.2967/jnumed.124.269431.
PubMed
Abstract available
Evolution of Active Surveillance of Prostate Cancer: Impact of MRI, MRI-guided
Biopsy and Focal Therapy.
J Urol. 2025 Apr 21:101097JU0000000000004559. doi: 10.1097/JU.0000000000004559.
PubMed
Abstract available
Correction: Optimal length and temporal resolution of dynamic contrast-enhanced
MR imaging for the differentiation between prostate cancer and normal peripheral
zone tissue.
PLoS One. 2025;20:e0322895.
PubMed
Abstract available
Valosin-Containing Protein (VCP/p97) Mediates Neuroendocrine Differentiation in
Prostate Cancer Cells Through Pim1 Signaling Inducing Autophagy.
Prostate. 2025 Apr 23. doi: 10.1002/pros.24900.
PubMed
Abstract available
Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for
Prostate Cancer in Patients With Lower Urinary Tract Symptoms.
Prostate. 2025 Apr 24. doi: 10.1002/pros.24906.
PubMed
Abstract available
Thank you for your interest in scientific medicine.